Cefdinir
Product Images NDC 50090-5583

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 50090-5583). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cefdinir Str)

Chemical structure diagram of the active ingredient Cefdinir. The structure depicts various atoms including nitrogen, sulfur, oxygen, carbon, and hydrogen, arranged to illustrate the molecule's chemical composition.*

FDA Label Image

Label Image (Lbl500905583)

Cefdinir oral suspension powder label by A-S Medication Solutions, NDC 50090-5583-0. The label indicates a concentration of 250 mg per 5 mL after reconstitution, with each 5 mL containing cefdinir 250 mg. It instructs to store the dry powder and reconstituted suspension at 68 to 77 degrees Fahrenheit and to use the medicine within 14 days of reconstitution. The product is distributed by A-S Medication Solutions, Libertyville, IL 60048.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.